Myriad Genetics | MYGN - Pre Tax Profit


Myriad Genetics reported $4.6M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Agilent USD 442M 1000K Sep/2025
Becton, Dickinson and Co. USD 393M 117M Dec/2025
Bio-Rad Laboratories USD 82.9M 331.1M Sep/2025
Bruker USD -72.6M 73.1M Sep/2025
Danaher USD 1.08B 421M Sep/2025
Hologic USD 229.7M 2.3M Dec/2025
Illumina USD 220M 86M Sep/2025
J&J USD 4.97B 2.53B Dec/2025
Mettler Toledo International USD 269.24M 20.58M Sep/2025
Myriad Genetics USD 4.6M 3.4M Dec/2025
OraSure Technologies USD -18.43M 5.14M Dec/2025
Pacific Biosciences Of California USD -40.17M 2.55M Dec/2025
Quest Diagnostics USD 336M 57M Sep/2025
Quidel USD -756.9M 527.3M Sep/2025
Repligen USD 17.11M 10.25M Sep/2025
Revvity USD 55.68M 115.97M Sep/2025
Standard Biotools USD -22.03M 10.87M Dec/2025
Thermo Fisher Scientific USD 2.12B 295M Dec/2025
Veracyte USD 40.63M 21.74M Dec/2025
Waters USD 170.12M 7.57M Sep/2025